Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of primary brain tumor, with an average survival time of less than two years following diagnosis, and current treatments have proven largely ineffective. In recent years, immunotherapies […]
Source link